These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 15214879)

  • 1. Invasive Streptococcus pneumoniae from Portugal: implications for vaccination and antimicrobial therapy.
    Serrano I; Ramirez M; Melo-Cristino J;
    Clin Microbiol Infect; 2004 Jul; 10(7):652-6. PubMed ID: 15214879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in Streptococcus pneumoniae serotypes causing invasive disease with non-universal vaccination coverage of the seven-valent conjugate vaccine.
    Aguiar SI; Serrano I; Pinto FR; Melo-Cristino J; Ramirez M;
    Clin Microbiol Infect; 2008 Sep; 14(9):835-43. PubMed ID: 18844684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotype distribution and antimicrobial resistance patterns of Streptococcus pneumoniae isolated from children in China younger than 5 years.
    Liu Y; Wang H; Chen M; Sun Z; Zhao R; Zhang L; Wang H; Zhang H; Wang L; Chu Y; Liu Y; Ni Y
    Diagn Microbiol Infect Dis; 2008 Jul; 61(3):256-63. PubMed ID: 18358662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of the pneumococcal conjugate vaccine on serotype distribution and antimicrobial resistance of invasive Streptococcus pneumoniae isolates in Dallas, TX, children from 1999 through 2005.
    Messina AF; Katz-Gaynor K; Barton T; Ahmad N; Ghaffar F; Rasko D; McCracken GH
    Pediatr Infect Dis J; 2007 Jun; 26(6):461-7. PubMed ID: 17529859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Has the licensing of respiratory quinolones for adults and the 7-valent pneumococcal conjugate vaccine (PCV-7) for children had herd effects with respect to antimicrobial non-susceptibility in invasive Streptococcus pneumoniae?
    Fenoll A; Aguilar L; Granizo JJ; Giménez MJ; Aragoneses-Fenoll L; Mendez C; Tarragó D
    J Antimicrob Chemother; 2008 Dec; 62(6):1430-3. PubMed ID: 18819966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional differences in serotype distribution, pneumococcal vaccine coverage, and antimicrobial resistance of invasive pneumococcal disease among German federal states.
    Imöhl M; Reinert RR; van der Linden M
    Int J Med Microbiol; 2010 Apr; 300(4):237-47. PubMed ID: 19604721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serotypes and antimicrobial susceptibilities of 1033 pneumococci isolated from children in Greece during 2001-2004.
    Paraskakis I; Kafetzis DA; Chrisakis A; Papavasilliou H; Kirikou H; Pangalis A; Tzouvelekis LS; Athanasiou T; Legakis NJ;
    Clin Microbiol Infect; 2006 May; 12(5):490-3. PubMed ID: 16643530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotype 19A is the most common Streptococcus pneumoniae isolate in children with chronic sinusitis.
    McNeil JC; Hulten KG; Mason EO; Kaplan SL
    Pediatr Infect Dis J; 2009 Sep; 28(9):766-8. PubMed ID: 19636285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased antimicrobial resistance among nonvaccine serotypes of Streptococcus pneumoniae in the pediatric population after the introduction of 7-valent pneumococcal vaccine in the United States.
    Farrell DJ; Klugman KP; Pichichero M
    Pediatr Infect Dis J; 2007 Feb; 26(2):123-8. PubMed ID: 17259873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adult invasive pneumococcal disease between 2003 and 2006 in North-Rhine Westphalia, Germany: serotype distribution before recommendation for general pneumococcal conjugate vaccination for children <2 years of age.
    Imöhl M; Reinert RR; van der Linden M
    Clin Microbiol Infect; 2009 Nov; 15(11):1008-12. PubMed ID: 19681946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inferring the potential success of pneumococcal vaccination in Italy: serotypes and antibiotic resistance of Streptococcus pneumoniae isolates from invasive diseases.
    Pantosti A; Boccia D; D'Ambrosio F; Recchia S; Orefici G; Moro ML; ;
    Microb Drug Resist; 2003; 9 Suppl 1():S61-8. PubMed ID: 14633369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nationwide surveillance of Streptococcus pneumoniae in Greece: patterns of resistance and serotype epidemiology.
    Poulakou G; Katsarolis I; Matthaiopoulou I; Tsiodras S; Kanavaki S; Hatzaki D; Roilides E; Sofianou D; Kavaliotis I; Kansouzidou A; Kafetzis DA; Paraskakis I; Foustoukou M; Daikos GL; Syriopoulou V; Pangalis A; Leveidiotou S; Giamarellou H;
    Int J Antimicrob Agents; 2007 Jul; 30(1):87-92. PubMed ID: 17540542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in pneumococcal serotypes and antibiotypes carried by vaccinated and unvaccinated day-care centre attendees in Portugal, a country with widespread use of the seven-valent pneumococcal conjugate vaccine.
    Sá-Leão R; Nunes S; Brito-Avô A; Frazão N; Simões AS; Crisóstomo MI; Paulo AC; Saldanha J; Santos-Sanches I; de Lencastre H
    Clin Microbiol Infect; 2009 Nov; 15(11):1002-7. PubMed ID: 19392883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of antibiotic-resistant Streptococcus pneumoniae infections and the use of pneumococcal conjugate vaccines.
    Picazo JJ
    Clin Microbiol Infect; 2009 Apr; 15 Suppl 3():4-6. PubMed ID: 19366362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotypes 1, 7F and 19A became the leading causes of pediatric invasive pneumococcal infections in Portugal after 7 years of heptavalent conjugate vaccine use.
    Aguiar SI; Brito MJ; Gonçalo-Marques J; Melo-Cristino J; Ramirez M
    Vaccine; 2010 Jul; 28(32):5167-73. PubMed ID: 20558247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotype distribution and antimicrobial resistance patterns of nasopharyngeal and invasive Streptococcus pneumoniae isolates in Hong Kong children.
    Ho PL; Lam KF; Chow FK; Lau YL; Wong SS; Cheng SL; Chiu SS
    Vaccine; 2004 Sep; 22(25-26):3334-9. PubMed ID: 15308357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changing epidemiology of antimicrobial-resistant Streptococcus pneumoniae in the United States, 2004-2005.
    Richter SS; Heilmann KP; Dohrn CL; Riahi F; Beekmann SE; Doern GV
    Clin Infect Dis; 2009 Feb; 48(3):e23-33. PubMed ID: 19115971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotype coverage of pneumococcal conjugate vaccine and drug susceptibility of Streptococcus pneumoniae isolated from invasive or non-invasive diseases in central Thailand, 2006-2009.
    Srifeungfung S; Tribuddharat C; Comerungsee S; Chatsuwan T; Treerauthanaweeraphong V; Rungnobhakhun P; Nunthapisud P; Chokephaibulkit K
    Vaccine; 2010 Apr; 28(19):3440-4. PubMed ID: 20199759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution of serotypes and antibiotic resistance of invasive pneumococcal disease isolates among children aged 5 years and under in Saudi Arabia (2000-2004).
    Shibl AM
    Clin Microbiol Infect; 2008 Sep; 14(9):876-9. PubMed ID: 18844690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergence of Streptococcus pneumoniae serotypes 19A, 6C, and 22F and serogroup 15 in Cleveland, Ohio, in relation to introduction of the protein-conjugated pneumococcal vaccine.
    Jacobs MR; Good CE; Bajaksouzian S; Windau AR
    Clin Infect Dis; 2008 Dec; 47(11):1388-95. PubMed ID: 18959493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.